BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2401848)

  • 21. Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells.
    Bridges KR; Smith BR
    J Clin Invest; 1985 Sep; 76(3):913-8. PubMed ID: 2995450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of transferrin receptor mRNA by transferrin-gallium in human myeloid HL60 and lymphoid CCRF-CEM leukaemic cells.
    Ul-Haq R; Chitambar CR
    Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):873-7. PubMed ID: 8379943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron uptake from transferrin and transferrin endocytic cycle in Friend erythroleukemia cells.
    Hradilek A; Neuwirt J
    J Cell Physiol; 1987 Oct; 133(1):192-6. PubMed ID: 3478338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of iron supply in the regulation of 5-aminolevulinate synthase mRNA levels in murine erythroleukemia cells.
    Fuchs O; Ponka P
    Neoplasma; 1996; 43(1):31-6. PubMed ID: 8843957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron and copper requirements for proliferation and differentiation of a human promyelocytic leukemia cell line (HL-60).
    Sergeant S; Johnson WT
    J Cell Physiol; 1995 Jun; 163(3):477-85. PubMed ID: 7775591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demonstration of the specific binding of bovine transferrin to the human transferrin receptor in K562 cells: evidence for interspecies transferrin internalization.
    Tsavaler L; Stein BS; Sussman HH
    J Cell Physiol; 1986 Jul; 128(1):1-8. PubMed ID: 3013902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.
    Richardson DR; Tran EH; Ponka P
    Blood; 1995 Dec; 86(11):4295-306. PubMed ID: 7492790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of transferrin receptor in myeloid and monocytic differentiation of HL-60 leukemia cells.
    Ho PT; Ishiguro K; Sartorelli AC
    Cancer Res; 1989 Apr; 49(8):1989-95. PubMed ID: 2702640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Interrelation between transferrin receptor expression and intracellular ferritin concentration in leukemia cells and normal marrow cells].
    Rhyner K; Taetle R
    Schweiz Med Wochenschr; 1986 Oct; 116(43):1484-7. PubMed ID: 3787230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of uptake of transferrin-bound iron by human hepatoma cells by nontransferrin-bound iron.
    Trinder D; Morgan E
    Hepatology; 1997 Sep; 26(3):691-8. PubMed ID: 9303500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mobilization of intracellular iron by analogs of pyridoxal isonicotinoyl hydrazone (PIH) is determined by the membrane permeability of the iron-chelator complexes.
    Buss JL; Arduini E; Ponka P
    Biochem Pharmacol; 2002 Dec; 64(12):1689-701. PubMed ID: 12445858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of iron from endosomes is an early step in the transferrin cycle.
    Bakkeren DL; de Jeu-Jaspars CM; Kroos MJ; van Eijk HG
    Int J Biochem; 1987; 19(2):179-86. PubMed ID: 2883038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The release of iron and transferrin from the human melanoma cell.
    Richardson DR; Baker E
    Biochim Biophys Acta; 1991 Feb; 1091(3):294-302. PubMed ID: 2001412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The soluble transferrin receptor: biological aspects and clinical usefulness as quantitative measure of erythropoiesis.
    Beguin Y
    Haematologica; 1992; 77(1):1-10. PubMed ID: 1398274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Release of soluble transferrin receptor from the surface of human leukemic HL60 cells.
    Chitambar CR; Zivkovic Z
    Blood; 1989 Aug; 74(2):602-8. PubMed ID: 2752136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism and clinical significance of soluble hepatic cell-surface receptors.
    Kohgo Y; Kondo H; Mogi Y; Niitsu Y
    Targeted Diagn Ther; 1991; 4():305-19. PubMed ID: 1797162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Replacement of transferrin in serum-free cultures of mitogen-stimulated mouse lymphocytes by a lipophilic iron chelator.
    Brock JH; Stevenson J
    Immunol Lett; 1987 May; 15(1):23-5. PubMed ID: 3610230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of transferrin receptor expression in myeloid leukemia cells.
    Taetle R; Ralph S; Smedsrud S; Trowbridge I
    Blood; 1987 Sep; 70(3):852-9. PubMed ID: 3476165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A lipophilic iron chelator can replace transferrin as a stimulator of cell proliferation and differentiation.
    Landschulz W; Thesleff I; Ekblom P
    J Cell Biol; 1984 Feb; 98(2):596-601. PubMed ID: 6693498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.